Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

6.1K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of DNA encoded library and machine learning model combinations for hit discovery.

npj drug discovery·2026
Same author

Youth Empowered Self-Care: a direct-to-participant intervention to promote mental well-being.

BMC public health·2026
Same author

Nanoparticle-mediated inhibition of Yes-associated protein prevents corneal scarring after traumatic injury.

Materials today. Bio·2026
Same author

Compound Heterozygous Variants in the Phospholipase Gene PNPLA6 Cause Hypopituitarism and Vision Loss.

Human mutation·2026
Same author

<i>In situ</i>rheological monitoring of diffusion-controlled hydrogel crosslinking for embedded 3D bioprinting.

Biofabrication·2026
Same author

Semaglutide and Neovascular Age-Related Macular Degeneration Among Adults with Type 2 Diabetes: An OHDSI Network Study.

Ophthalmology·2026
Same journal

Split-Spectrum Amplitude-Decorrelation Optoretinography Detects Impaired Photoreceptor Function in Age-Related Macular Degeneration.

Ophthalmology science·2026
Same journal

Genome-Wide Association Study for Glucocorticoid-Induced Ocular Hypertension.

Ophthalmology science·2026
Same journal

Assessing Polypoidal Choroidal Vasculopathy-Related OCT Features in the TENAYA and LUCERNE Trials.

Ophthalmology science·2026
Same journal

Quantitative Analysis of Choroidal Thickness and Blood Flow in Thyroid-Associated Ophthalmopathy Using Ultra-Widefield Swept-Source OCT Angiography.

Ophthalmology science·2026
Same journal

Epiretinal Membrane Is Associated with Acquired Vitelliform Lesion Morphometrics in Intermediate Age-Related Macular Degeneration.

Ophthalmology science·2026
Same journal

Multisource Machine Learning Model for Detecting Referral-Warranted Retinopathy of Prematurity.

Ophthalmology science·2026
See all related articles

Related Experiment Video

Updated: Jan 14, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.7K

Autonomous Artificial Intelligence in Diabetic Retinopathy Testing-Lessons Learned on Successful Health System

Clare W Teng1, Saawan D Patel1, Andrew J Barkmeier2

  • 1Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

Ophthalmology Science
|October 27, 2025
PubMed
Summary
This summary is machine-generated.

Artificial intelligence (AI) for diabetic retinopathy (DR) testing shows promise for early detection and improved access. Successful implementation requires strategic management of technology, operations, and stakeholder engagement for better patient outcomes.

Keywords:
Autonomous artificial intelligenceDiabetic retinopathy testingHealth system adoptionSuccess factorsValue propositions

More Related Videos

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

786
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

8.2K

Related Experiment Videos

Last Updated: Jan 14, 2026

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats
07:41

Behavioral Assessment of Visual Function via Optomotor Response and Cognitive Function via Y-Maze in Diabetic Rats

Published on: October 23, 2020

6.7K
Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System
05:33

Introduction of an Integrated Pathology Image Management, Artificial Intelligence, and Reporting System

Published on: July 11, 2025

786
An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy
08:10

An Ex Vivo Tissue Culture Model for Fibrovascular Complications in Proliferative Diabetic Retinopathy

Published on: January 25, 2019

8.2K

Area of Science:

  • Ophthalmology
  • Medical Technology
  • Artificial Intelligence

Background:

  • Artificial intelligence (AI)-aided diabetic retinopathy (DR) testing systems have been available for five years, yet their adoption in clinical practice remains limited.
  • Understanding the evidence for AI in DR testing and identifying successful implementation strategies is crucial for wider adoption.

Purpose of the Study:

  • To summarize existing evidence on AI-aided DR testing in clinical settings.
  • To describe the current adoption status of AI DR testing systems.
  • To identify key themes for successful implementation of AI DR testing.

Main Methods:

  • A literature review was conducted to identify studies on AI-aided DR testing performance and impact.
  • Interviews were held with ophthalmologists implementing AI DR testing programs in academic health systems.
  • The study focused on three FDA-cleared AI systems: LumineticsCore, EyeArt, and AEYE-DS.

Main Results:

  • Literature review identified six publications on diagnostic accuracy, with additional articles on adherence, equity, cost, and workflow.
  • AI systems demonstrated average nonmydriatic gradability of 49%-75%, sensitivity of 87%-100%, and specificity of 60%-91%.
  • Successful implementation involves proper site selection, workflow integration, streamlined patient engagement, and staff training, leading to improved quality measures, equity, productivity, and adherence.

Conclusions:

  • AI-aided diabetic eye examinations offer a promising approach for early DR detection, enhanced access, and cost reduction.
  • Successful integration necessitates addressing technological, operational, and stakeholder engagement challenges.
  • Strategic management of AI adoption is key to realizing its potential in revolutionizing eye care delivery.